Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CFTR | P13569 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL29126721 | 0.97 | CA2 (0.50) | CA2CA4CA5ACFTRALOX15 | |
| SCHEMBL524346 | 0.78 | CA2 (0.50) | CA2CA4CA5ACFTRALOX15 | |
| SCHEMBL13109422 | 0.78 | CA2 (0.50) | CA2CA4CA5ACFTRALOX15 | |
| Triphenylphosphine Oxide SCHEMBL8431247 | 0.77 | CA2 (0.63) | CA2CA4CA5ACFTRALOX15 | |
| Triphenylphosphine Oxide SCHEMBL8431251 | 0.77 | CA2 (0.63) | CA2CA4CA5ACFTRALOX15 | |
| SCHEMBL30604627 | 0.76 | CA2 (0.48) | CA2CA4CA5ACFTRALOX15 | |
| Potassium SCHEMBL30627046 | 0.76 | CA2 (0.48) | CA2CA4CA5ACFTRALOX15 | |
| SCHEMBL9617518 | 0.74 | CA2 (0.52) | CA2CA4CA5ACFTRGAA | |
| SCHEMBL27300024 | 0.74 | CA2 (0.46) | CA2CA4CA5ACFTRALOX15 | |
| SCHEMBL524587 | 0.74 | CA2 (0.46) | CA2CA4CA5ACFTRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119241622-B | 3′-ONH2Synthesis method of ribonucleotide | 凯莱英生命科学技术(天津)有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119241622-A | 3′-ONH2Synthesis method of ribonucleotide | 凯莱英生命科学技术(天津)有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-118344239-A | Method for efficiently constructing carbon-carbon bond by nitrogen deletion reaction | 南京大学 | 2024-07-16 | — | — | CN | claimed |
| CN-115353184-B | Surface modified chitosan-agar flocculant and preparation method and application thereof | 湖南仁和环境股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-113620274-A | Method for preparing lignin-based carbon quantum dots with high quantum yield quickly, simply and conveniently | 广东工业大学 | 2021-11-09 | — | — | CN | claimed |
| CN-112552339-A | Preparation method of O-diphenylphosphoryl hydroxylamine | 安徽昊帆生物有限公司 | 2021-03-26 | — | — | CN | claimed |
| CN-108047156-B | 5-methylmorpholine-3-amino-2-oxazolidinyl ketone antigen with spiro structure, antibody, preparation and application | 华南农业大学 | 2020-08-07 | — | — | CN | claimed |
| EP-1931341-B1 | 1H-INDOLE-PYRIDINECARBOXAMIDE AND 1H-INDOLE-PIPERIDINECARBOXAMIDE DERIVATIVES AND THEIR USE AS TYROSINE HYDROXYLASE INDUCERS | SERVIER LAB (FR) | 2009-11-04 | — | — | EP | claimed |
| WO-2006127368-A2 | METHODS FOR SYNTHESIZING IMIDAZOTRIAZINONES | LEXICON GENETICS INCORPORATED (US) | 2006-11-30 | — | — | WO | claimed |
| CN-122071464-A | Heterocyclic compound, pharmaceutical composition thereof and application thereof | 上海璎黎药业有限公司 | 2026-05-22 | — | — | CN | disclosed |
| US-20260132136-A1 | Pyrazolo[5,1-f][1,2,4]triazin-4-ones as inhibitors of NOX4 | BOEHRINGER INGELHEIM INT GMBH (DE) | 2026-05-14 | — | — | US | disclosed |
| US-12624044-B2 | SMARCA degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| CN-122000468-A | High-temperature-resistant electrolyte and lithium ion battery | 国网湖南省电力有限公司防灾减灾中心 | 2026-05-08 | — | — | CN | disclosed |
| EP-4313980-B1 | LACTIVICIN COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS | FEDORA PHARMACEUTICALS INC (CA) | 2026-04-22 | — | — | EP | disclosed |
| WO-1990012012-A1 | SUBSTITUTED PHENYLTRIAZOLOPYRIMIDINE HERBICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-10-18 | — | — | WO | disclosed |
| US-4956470-A | BACTERICIDES, FUNGICIDES, ANTHELMINTICS, ANTIPROTOZOA AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1990-09-11 | — | — | US | disclosed |
| EP-0353902-A1 | Substituted phenyltriazolopyrimidine herbicides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-02-07 | — | — | EP | disclosed |
| US-4831151-A | NEMATOCIDES | HOFFMANN-LA ROCHE INC. (US) | 1989-05-16 | — | — | US | disclosed |
| US-4814332-A | PARASITICIDES | HOFFMAN-LA ROCHE INC. (US) | 1989-03-21 | — | — | US | disclosed |
| US-4808727-A | CHEMICAL INTERMEDIATES FOR WATER-SOLUBLE SALTS OF PARASITICIDES | HOFFMANN-LAROCHE INC. (US) | 1989-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132136-A1 | Pyrazolo[5,1-f][1,2,4]triazin-4-ones as inhibitors of NOX4 | NOX4, NOX1, NOX3 | CA2 937/4885CA4 2248/4885CA5A 317/4885 |
| US-12624044-B2 | SMARCA degraders and uses thereof | SMARCA1, SMARCC1, SMARCA2 | CA2 2413/4885CA4 2933/4885CA5A 3808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.